Marginal elevation of blood lipids
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) BMI=24 kg/m2; (2) In line with Western medicine borderline hyperlipidemia diagnosis; (3) Age =18 years old, male or female; (4) Sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Combined with serious heart, brain and hematopoietic system and other primary diseases, combined with serious liver and kidney damage, there are malignant tumors; (2) in preparation for pregnancy, pregnancy or lactation period; (3) Combined with a major mental illness, unable to cooperate or unwilling to cooperate; (4) known allergy to the drug ingredient; (5) People who have taken weight-loss or lipid-regulating drugs in the past 3 months, affecting the judgment of the results; (6) Weak spleen and stomach, easy loose stool diarrhea, or accompanied by intestinal diseases; (7) Participants in other clinical trials in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| tetrapolipidemia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum metabolomics;IL-6;TNF-a;Physical improvement;MCP-1;weight;NF-?B; | — |
Countries
China
Contacts
The Affiliated Hospital of Jiangxi University of Chinese Medicine